IP Verse

Retroviral Transduction Using Poloxamers

PatentPatent Analysis

EP3763820

HELMHOLTZ ZENTRUM MNCHEN DEUTSCHES FORSCHUNGSZENTRUM FR GESUNDHEIT UND UMWELT
Application Number
EP20188488A
Filing Date
Feb 28, 2013
Status
Granted And Under Opposition
Nov 19, 2021
Grant Date
Dec 22, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2922393B2
EP2820138B1
EP2946721B1

Bibliography

The patent EP3763820B1 was granted to Helmholtz Zentrum Mnchen Deutsches Forschungszentrum FR Gesundheit UND Umwelt on Dec 22, 2021 following the initial filing on Feb 28, 2013 under the application number EP20188488A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

KONIG SZYNKA TILMANN VON RENESSESep 22, 2022ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents